Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice
- 27 March 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 576 (1) , 139-142
- https://doi.org/10.1016/0006-8993(92)90619-k
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuliPharmacology Biochemistry and Behavior, 1991
- Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic ratsPharmacology Biochemistry and Behavior, 1990
- [3H][D-Ala2,NMePhe4,Gly-ol5]-enkephalin (mu-opioid) binding in beige-J micePeptides, 1988
- The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermatesLife Sciences, 1988
- C57BL/6J-bg J (beige) mice: Differential sensitivity in the tail flick test to centrally administered MU- and delta-opioid receptor agonistsLife Sciences, 1987
- Differential Regulation by Guanine Nucleotides of Opiate Agonist and Antagonist Receptor InteractionsJournal of Neurochemistry, 1980
- Identification of novel high affinity opiate receptor binding in rat brainNature, 1975